News | May 29, 2024
IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Inducts advanced AI-Powered 24x7 remote patient monitoring system
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Multi-ethnic innovation helps all complexions appear clearer and more uniform
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
hey were educated about the 7- step hand-washing technique trainings
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Subscribe To Our Newsletter & Stay Updated
